Clinical Trial

The Impact of Artificial Intelligence Electrocardiography on Occlusion Myocardial Infarction Management Under the Value-Based Payment System

Recruiting
View on ClinicalTrials.gov →
Summary
This trial will prospectively evaluate the impact of integrating AI-ECG within the pay-for-performance program on improving the diagnosis, treatment, and clinical outcomes of occlusion myocardial infarction patients by promoting accurate and timely diagnoses through financial incentives.
Protocol Amendment History 2 amendments
This ClinicalTrials.gov record has been amended 2 times since 2025-03-13; most recent amendment 2026-04-06.
Status change: Not Yet Recruiting → Recruiting 2026-04-06
Trial Details
NCT Number NCT06887699
Lead Sponsor National Defense Medical Center, Taiwan
Conditions OMI - Occlusion Myocardial Infarction, Artificial Intelligence (AI), Electrocardiogram, Cost-effectiveness Analysis
Enrollment 212,000 participants
Start Date 2025-08-01
Primary Completion 2028-03-31 (estimated)
Study Completion 2028-06-30 (estimated)
Updated on ClinicalTrials.gov 2026-04-09